Psoriasis in the era of targeted cancer therapeutics: a systematic review on de novo and pre-existing psoriasis in oncologic patients treated with emerging anti …
V Madan, LI Ortiz-López, G Sakunchotpanit… - Dermatology and …, 2024 - Springer
New advancements in medicine have paved the way for targeted therapies and immune
checkpoint inhibitors (ICIs), which have become mainstays of cancer therapy. Targeted …
checkpoint inhibitors (ICIs), which have become mainstays of cancer therapy. Targeted …
Computer-aided drug discovery of c-Abl kinase inhibitors from plant compounds against chronic myeloid leukemia
Chronic myeloid leukemia (CML) is a hematological malignancy characterized by the
neoplastic transformation of hematopoietic stem cells, driven by the Philadelphia (Ph) …
neoplastic transformation of hematopoietic stem cells, driven by the Philadelphia (Ph) …
[HTML][HTML] Antidepressants and the risk of psoriasis induction: A case–control study
Background: Psoriasis (PSO) is a common chronic autoimmune skin disease with a
significant psycho-socio-economic burden. Some antidepressants (ADs) such as fluoxetine …
significant psycho-socio-economic burden. Some antidepressants (ADs) such as fluoxetine …
[PDF][PDF] Nilotinib-induced confluent and reticulated papillomatosis in a patient with chronic myeloid leukemia
A Samal, M Panda, A Biswal - 2023 - cosmoderma.org
Tyrosine kinase inhibitors (TKIs) are anticancer drugs which are being used for the targeted
treatment of various malignancies. Nilotinib is a second-generation TKI used in the treatment …
treatment of various malignancies. Nilotinib is a second-generation TKI used in the treatment …